Tactile Systems Technology, Inc. (TCMD)

US — Healthcare Sector
Peers: CNMD  TMCI  SRDX  LIVN  RXST  AXGN  LUNG  OFIX  CVRX  AXDX  NPCE  ANIK  KIDS  SGHT  FNA  IRTC  HSKA  ELMD 

Automate Your Wheel Strategy on TCMD

With Tiblio's Option Bot, you can configure your own wheel strategy including TCMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol TCMD
  • Rev/Share 12.3642
  • Book/Share 8.6725
  • PB 1.1796
  • Debt/Equity 0.0886
  • CurrentRatio 4.5231
  • ROIC 0.0606

 

  • MktCap 237831132.0
  • FreeCF/Share 1.5926
  • PFCF 6.2982
  • PE 14.9775
  • Debt/Assets 0.065
  • DivYield 0
  • ROE 0.078

 

  • Rating A
  • Score 4
  • Recommendation Buy
  • P/E Score 2
  • DCF Score 5
  • P/B Score 3
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade TCMD Piper Sandler Overweight Neutral -- $14 May 6, 2025
Downgrade TCMD B. Riley Securities Buy Neutral $23 $18 Feb. 19, 2025
Initiation TCMD B. Riley Securities -- Buy -- $23 Sept. 26, 2024

News

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors
TCMD
Published: June 03, 2025 by: GlobeNewsWire
Sentiment: Neutral

Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors

Read More
image for news New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors
Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript
TCMD
Published: May 05, 2025 by: Seeking Alpha
Sentiment: Neutral

Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q1 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Margaret Kaczor Andrew - William Blair Ryan Zimmerman - BTIG Anderson Schock - B. Riley Securities Operator Welcome, ladies and gentlemen, to the First Quarter 2025 Earnings Conference Call for Tactile Medical.

Read More
image for news Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript
Tactile Systems Technology, Inc. (TCMD) Q4 2024 Earnings Call Transcript
TCMD
Published: February 18, 2025 by: Seeking Alpha
Sentiment: Neutral

Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q4 2024 Earnings Conference Call February 18, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Max Smock - William Blair Adam Maeder - Piper Sandler Iseult McMahon - BTIG Kyle Bauser - B. Riley Securities Suraj Kalia - Oppenheimer & Company Operator Please standby.

Read More
image for news Tactile Systems Technology, Inc. (TCMD) Q4 2024 Earnings Call Transcript
Tactile Systems Technology (TCMD) Tops Q4 Earnings and Revenue Estimates
TCMD
Published: February 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.38 per share a year ago.

Read More
image for news Tactile Systems Technology (TCMD) Tops Q4 Earnings and Revenue Estimates

About Tactile Systems Technology, Inc. (TCMD)

  • IPO Date 2016-07-28
  • Website https://www.tactilemedical.com
  • Industry Medical - Devices
  • CEO Ms. Sheri Louise Dodd
  • Employees 1037

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.